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ARTICLE
Glucose metabolism induced by Bmp signaling is
essential for murine skeletal development
Seung-Yon Lee 1, E. Dale Abel 2 & Fanxin Long1,3,4
Much of the mammalian skeleton originates from a cartilage template eventually replaced by
bone via endochondral ossiﬁcation. Despite much knowledge about growth factors and
nuclear proteins in skeletal development, little is understood about the role of metabolic
regulation. Here we report that genetic deletion of the glucose transporter Glut1 (Slc2a1),
either before or after the onset of chondrogenesis in the limb, severely impairs chondrocyte
proliferation and hypertrophy, resulting in dramatic shortening of the limbs. The cartilage
defects are reminiscent to those caused by deﬁciency in Bmp signaling. Importantly, deletion
of Bmpr1a in chondrocytes markedly reduces Glut1 levels in vivo, whereas recombinant BMP2
increases Glut1 mRNA and protein levels, boosting glucose metabolism in primary chon-
drocytes. Biochemical studies identify a Bmp-mTORC1-Hif1a signaling cascade resulting in
upregulation of Glut1 in chondrocytes. The results therefore uncover a hitherto unknown
connection between Bmp signaling and glucose metabolism in the regulation of cartilage
development.
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A majority of the bony skeleton in mammals, includinglong bones in the limbs, is derived from a cartilage tem-plate through endochondral ossiﬁcation. During
embryonic limb development, mesenchymal cells descended from
the lateral plate mesoderm undergo chondrogenesis to form a
cartilage anlage composed of chondrocytes surrounded by several
layers of ﬁbroblastic cells in the perichondrium1,2. The chon-
drocytes initially all undergo proliferation, but subsequently those
residing at center of the cartilage anlage exit the cell cycle and
undergo cellular hypertrophy. Recent studies have indicated that
chondrocyte hypertrophy encompasses three distinct phases,
including two with proportional increases in dry mass production
and ﬂuid uptake together with an intervening phase of cell
swelling3. Although the terminally hypertrophic chondrocytes are
traditionally believed to all undergo apoptosis, recent evidence
indicates that a subpopulation may survive to produce osteo-
blasts4–6. The hypertrophic cartilage is subsequently invaded by
blood vessels that not only initiate the formation of the bone
marrow but also introduce osteoblast progenitors from the peri-
chondrium for endochondral bone formation7. Once the bone
marrow cavity is established, chondrocytes form the growth plate
composed of discreet domains including proliferation and
hypertrophy zones, at either end of the cartilage template. The
proliferating chondrocytes can be further distinguished as round
cells near the ends versus ﬂat cells next to the hypertrophy region.
As the ﬂat cells are stacked into columns along the longitudinal
axis, they are often referred to as columnar cells. While the car-
tilage template continues to grow at the ends due to proliferation
and hypertrophy, it is progressively replaced by bone and the
expanding marrow cavity from the middle, following resorption
of the hypertrophic cartilage. Disruption of the normal sequence
of cartilage development is well documented to cause a myriad of
skeletal dysplasias in humans8. Thus, proper control and coor-
dination of chondrocyte proliferation and hypertrophy is critical
for ensuring the normal size and morphology of the skeleton.
Multiple growth factors have been implicated in regulating
chondrocyte proliferation and hypertrophy during endochondral
bone development1. For example, PTHrP, mainly expressed by
the perichondrial cells and chondrocytes at the ends of the car-
tilage elements, is critical for maintaining the proliferation zone
by activating a PP2A/HDAC4/MEF2 cascade through the PTHR1
receptor to prevent premature onset of hypertrophy9–11. The
pace-keeping function of PTHrP is mediated through Ihh that is a
necessary and direct inducer of PTHrP expression in the peri-
articular region12–14. As Ihh is only expressed in the pre-
hypertrophic and early hypertrophic chondrocytes and thus
suppressed by PTHrP signaling, it forms a negative feedback loop
with PTHrP to ensure a proper rate of transition from pro-
liferation to hypertrophy15. Besides the indirect regulation of
hypertrophy, Ihh also directly promotes chondrocyte prolifera-
tion as well as the columnar organization of chondrocytes within
the proliferating zone14,16. Thus, Ihh together with PTHrP
represents a central mechanism for regulating cartilage
development.
Bmp signaling is also known to modulate multiple aspects of
skeletal development17. Studies have shown distinct expression
patterns for different members of the Bmp family, including
Bmp2, Bmp4 and Bmp5 in the perichondrium, Bmp2 and Bmp6 in
the hypertrophic chondrocytes and Bmp7 in the proliferating
chondrocytes18. Similarly, both type I and type II receptors for
Bmp signaling are expressed with characteristic patterns within
the growth plate. In particular, Bmpr1a is expressed highly in
columnar, prehypertrophic and hypertrophic chondrocytes,
coinciding with a high level of Smad1/5/8 phosphorylation,
indicating active canonical Bmp signaling18,19. More importantly,
deletion of Bmpr1a in chondrocytes impairs chondrocyte
proliferation, column formation as well as hypertrophy, whereas
additional removal of one Bmpr1b allele further exacerbates the
defects19. Similarly, inducible deletion of Bmpr1a in the cartilage
of newborn mice severely suppresses chondrocyte proliferation,
proteoglycan production and hypertrophy in the growth plate20.
Conversely, forced-expression of a constitutively active form of
Bmpr1a (caBmpr1a) in chondrocytes appears to accelerate the
transition from proliferation to hypertrophy21. However, the
mechanisms through which Bmp signaling promotes chondrocyte
proliferation and hypertrophy are not well understood.
Compared to the molecular regulators, much less is known
about potential metabolic changes accompanying cartilage
development. Although glucose is believed to be the main energy
source as well as a major precursor for proteoglycan synthesis in
chondrocytes, it is not known whether glucose uptake or meta-
bolism is regulated across the different zones in the growth plate.
An early study with a bioluminescence technique applied to
sections of the chicken epiphyseal growth cartilage shows that
glucose, glucose-6-phophate and lactate are present at the highest
level in the hypertrophic chondrocytes, thus associating active
glycolysis with hypertrophy22. However, a more recent study
reports that inhibition of glycolysis in chondrocytic cell lines with
NaF reduces intracellular ATP levels and causes hypertrophy-like
changes23. Thus, the relationship between glycolysis and chon-
drocyte hypertrophy remains unclear. In addition, although
multiple members of the Glut family have been implicated in
glucose transport in chondrocytes, the physiological relevance of
each transporter has not been demonstrated24. Finally, it is not
clear whether and how growth factors modulate glucose meta-
bolism in the developing cartilage. A recent study has indicated
that Igf2 deletion leads to elevated and imbalanced glucose
metabolism in the growth plate cartilage, but it remains unclear
whether such dysregulation is directly due to the loss of
Igf2 signaling or secondary to other changes25. Overall, further
studies are necessary to understand the potential role and
mechanism of metabolic regulation in skeletal development.
Here by genetic deletion we show that Glut1-mediated glucose
metabolism is dispensable for the formation of the initial cartilage
anlage, but is essential for the subsequent growth by supporting
chondrocyte proliferation, cartilage matrix production as well as
the transition to hypertrophy. Moreover, consistent with its
known function in promoting chondrocyte proliferation and
hypertrophy, Bmp signaling induces Glut1 transcription through
mTORC1 and Hif1a in chondrocytes.
Results
Dynamic expression of Glut1 in developing cartilage. As a ﬁrst
step to investigate the role of glucose metabolism in endochon-
dral skeletal development, we examined the expression pattern of
classic glucose transporters of the Glut family. RT-qPCR
experiments showed that Glut1 mRNA level was two-three
orders of magnitude higher than that of Glut2, Glut3, or Glut4 in
primary chondrocytes. Previous work by others has documented
that Glut1 mRNA was diffusively expressed throughout the limb
mesenchyme prior to the onset of chondrogenesis in the mouse
embryo, but was later upregulated in the cartilage primordia26.
Therefore we focused on characterizing the expression of Glut1
protein by immunoﬂuorescence staining. At E12.5 when skeletal
elements began to form in the limbs of mouse embryos, Glut1
was notably enriched in the cartilage anlagen over the sur-
rounding tissues (Fig. 1a, upper). At E14.5, Glut1 was elevated in
the middle of the cartilage template, coinciding with the onset of
chondrocyte hypertrophy (Fig. 1b, upper). By E16.5 and E18.5
when the growth plate cartilage was organized into discreet
domains, Glut1 was most highly expressed in the prehypertrophic
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and early hypertrophic regions, with apparent down-regulation in
the late hypertrophic chondrocytes (Fig. 1c, d, upper). A strong
Glut1 signal was also detected at the chondro-osseous junction
(primary spongiosa) immediately below the hypertrophic zone
(Fig. 1c, d, double-headed arrow). Co-staining with the endo-
thelium marker endomucin showed that the blood vessels at the
chondro-osseous junction expressed high levels of Glut1 (Fig. 1e).
At postnatal day 8 (P8), strong Glut1 expression persisted in the
early hypertrophic region and the primary spongiosa (Fig. 1f,
upper). In addition, Glut1 was elevated in the presumptive sec-
ondary ossiﬁcation center where chondrocytes were undergoing
hypertrophy (Fig. 1f, asterisk). Throughout the stages examined,
Glut1 expression in the perichondrium or bone collar was less
prominent than that in the prehypertrophic and early hyper-
trophic cartilage. Overall, Glut1 levels greatly increase in chon-
drocytes during the early phases of hypertrophy.
Dependence of skeletal growth on Glut1. To explore the
potential requirement of Glut1 in limb skeletal development, we
used Prx1-Cre to delete Glut1 in all of the limb mesenchyme
including precursors of chondrocytes and osteoblasts. Besides the
limbs, Prx1-Cre also targets the precursors for the calvarium or
the sterna. Immunostaining conﬁrmed that Glut1 protein was
essentially eliminated from the limb cartilage (but not the limb
vasculature) of the Prx1-Cre; Glut1f/f embryos (herein termed
Prx1-CKO) by E12.5 (Fig. 1a, lower). Examination of the later
stages (E14.5, E16.5, E18.5, P8) conﬁrmed complete absence of
Glut1 in the limb skeletal elements, whereas the expression in
endothelial cells (not targeted by Prx1-Cre) remained intact
(Fig. 1b–d, f, lower). The mutant mice developed to term and
survived postnatally but displayed obvious shortening of the
limbs at birth. Whole-mount skeletal staining at E18.5 conﬁrmed
that all limb skeletal elements were notably shorter in the Prx1-
CKO embryos than normal (Fig. 2a–c). The skull bones appeared
to be normal but the sternum was under-mineralized in the
mutant (Fig. 2d, e). The short limb phenotype was already
obvious at E16.5 when the scapula and the humerus also exhib-
ited hypomineralization, but both calvaria and sterna appeared
normal at this stage (Fig. 2f–j). At E14.5, the limb skeletal ele-
ments appeared to have a normal length but were under-
mineralized (Fig. 2k–m). Quantiﬁcation conﬁrmed that the femur
and the humerus essentially stopped growing after E14.5 in the
mutant (Fig. 2n, o). Remarkably, at E12.5 the cartilage anlagen in
the mutant embryo were largely normal in shape and size despite
efﬁcient elimination of Glut1 protein by Prx1-Cre at this stage, as
shown earlier (Fig. 2p-r). Thus, Glut1 in the limb mesenchyme
appears to be dispensable for the initial chondrogenesis but is
essential for the later skeletal growth in the mouse embryo.
Role of Glut1 in chondrocyte proliferation and hypertrophy.
We next evaluated the cellular defects in the long bones of the
Glut1 mutant mice. Despite the relatively normal skeletal length
at E14.5, H&E staining of the femur sections revealed a small but
consistent reduction of the emerging hypertrophic zone (Sup-
plementary Figure 1A). By E16.5, the mutant section lacked any
recognizable hypertrophic chondrocytes or bone marrow, and the
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Fig. 1 Genetic deletion with Prx1-Cre eliminates Glut1 in the long bones of the mouse. a Immunoﬂuorescence staining for Glut1 on longitudinal sections of
the forelimbs of E12.5 control (Ctrl) or mutant littermates (Prx1-CKO). Asterisk denotes cartilage elements. Note comparable expression in the vasculature
between control and mutant embryos. b–f Glut1 immunostaining on longitudinal sections of the femur of littermate control or mutant embryos at E14.5 (b),
E16.5 (c), E18.5 (d, e), and P8 (f). Boxed areas are shown at higher magniﬁcation to the right. Endomucin immunostaining in green marks endothelial cells
(e). Double arrowheads denote trabecular bone region (c, d, f). Scale bar: 100 µm (a–e) or 200 µm (f). Each image is representative of three animals
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presumptive marrow region was occupied by bony tissue that
appeared to be ingrowth of the bone collar (Fig. 3a). In addition,
the typical columnar organization of chondrocytes was entirely
missing in the mutant cartilage. The same histological abnorm-
alities were observed at E18.5 (Supplementary Figure 1B). Simi-
larly, no columnar or hypertrophic chondrocytes of the normal
morphology were observed in the mutant mouse at P8 (Fig. 3b,
blue box). Furthermore, whereas normally at P8 a secondary
hypertrophic zone formed within the epiphysis, preﬁguring the
secondary ossiﬁcation center, no such hypertrophy occurred in
the mutant cartilage (Fig. 3b, red box). As a result, no secondary
ossiﬁcation center developed in the mutant mouse at P16
(Fig. 3c). To conﬁrm the apparent defect in chondrocyte hyper-
trophy, we performed immunoﬂuorescence staining for collagen
X (ColX), a marker for hypertrophic chondrocytes. The results
showed the ColX-positive domain was much reduced at E14.5,
and virtually absent at E16.6, E18.5, and P8 in the mutant
(Fig. 3d). At P8, ColX was normally also evident in the secondary
hypertrophy zone, but it was not detectable in the equivalent area
in the mutant animal. MMP13, expressed by both terminal
hypertrophic chondrocytes and osteoblasts, was absent in the
cartilage of Prx1-CKO mice at either E16.5 or E18.5, even though
it was detected in the osteoblasts at E18.5 (Fig. 3e). Therefore,
both histology and molecular marker analyses demonstrate that
Glut1 is essential for proper chondrocyte hypertrophy.
We then examined the potential effect of Glut1 deletion on
chondrocyte proliferation. To discern the nascent chondrocytes
from the surrounding mesenchyme at E12.5, we performed
immunostaining for Sox9, and conﬁrmed that chondrogenesis
was essentially normal at the molecular level even though Glut1
was virtually undetectable in the cartilage anlagen (Supplemen-
tary Figure 2A). Moreover, EdU labeling experiments indicated
that Glut1 deletion did not impair the proliferation rate of Sox9+
cells at this stage (Supplementary Figure 2B, C). However, Glut1
deletion caused a marked reduction in EdU labeling throughout
the proliferative zone of the femur at E14.5, E16.5, and E18.5
(Fig. 4a, Supplementary Figure 2D, E). Quantiﬁcation within the
columnar region conﬁrmed that the percentage of EdU+
chondrocytes was reduced by ~50% at E14.5, and ~80% at
E16.5 or E18.5 in the absence of Glut1 (Fig. 4b). On the
other hand, TUNEL assays detected no obvious apoptosis in the
cartilage upon Glut1 deletion at any of the stages (Fig. 4c,
Supplementary Figure 2D, E). In fact, for reasons unknown at-
present, apoptosis normally detected at the interface of
the cartilage and the diaphyseal perichondrium appeared to
be suppressed in the mutant embryo (Fig. 4c, Supplementary
Figure 2D, E). Thus, Glut1 is critical for the proper prolifer-
ation of growth plate chondrocytes but dispensable for their
survival.
As a major function of chondrocytes is to produce extracellular
matrix proteins, we next asked whether Glut1 is required for this
process. Safranin O staining consistently detected a lower
intensity in the Glut1-deﬁcient cartilage at all stages examined,
suggesting a general decrease in proteoglycan levels (Fig. 4d,
Supplementary Figure 3). Quantiﬁcation of mRNA in the growth
plate cartilage with RT-PCR revealed that Glut1 deletion
markedly reduced the expression of Col2a1 and the proteoglycan
genes aggrecan (Acan), lumican (Lum), and epiphycan (Epyc)
(Fig. 4e). Therefore, Glut1 is critical for supporting the expression
of cartilage matrix genes by chondrocytes.
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Fig. 2 Deletion of Glut1 with Prx1-Cre leads to severe limb shortening. a–m, p–r Whole-mount skeletal staining of normal (Ctrl) or mutant (Prx1-CKO)
littermate embryos at E18.5 (a–e), E16.5 (f–j), E14.5 (k–m), and E12.5 (p–r). Red arrows denote hypomineralization of the mutant sternum compared to
control at E18.5. n, o Length measurements of femurs (n) and humeri (o) at indicated embryonic stages. *p < 0.05, n= 3, error bar indicates SD, two-way
ANOVA and Bonferroni post-test. Each image is representative of three mice
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Since previous studies have implicated Glut1 in osteoblast
differentiation, we examined bone formation in the Prx1-CKO
embryos26. Immunoﬂuorescence staining of Sp7 detected pre-
osteoblasts and osteoblasts in both the perichondrium/periosteum
and the primary ossiﬁcation center of wild type embryos at E16.5
(Fig. 5a, left). In the Prx1-CKO littermate, although a bone
marrow cavity was absent, preosteoblasts and osteoblasts were
abundant at the perichondrium/periosteum and have begun to
invade the center of the cartilage template (Fig. 5a, right).
Immunostaining of endomucin indicated that blood vessels were
abundant in the thickened bone collar but were just beginning to


























Fig. 3 Glut1 is indispensable for proper maturation of chondrocytes. a–e Histology of the femur at E16.5 (a), p8 (b), and p16 (c). Boxed areas shown at
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Fig. 4 Glut1 is necessary for chondrocyte proliferation and matrix production. a Representative images of EdU labeling (red) in the femur at E16.5. Region
between dashed lines is used for quantiﬁcation of labeling index. b EdU quantiﬁcation. *p < 0.05, n= 3 mice, error bar indicates SD, two-tailed Student’s t-
test. Scale bar: 250 µm. c, d Representative images of TUNEL (c) or Safranin O staining (d). e Gene expression assayed by RT-qPCR in cartilage. *p < 0.05,
n= 3 mice, error bar indicates SD, two-tailed Student’s t-test. Scale bar: 250 µm. Images are representative of three mice
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with Picrosirius Red conﬁrmed that the osteoblasts were actively
producing bone matrix in the mutant mice (Fig. 5c). However,
von Kossa staining revealed that mineralization of the bone
matrix was undetectable in the femur of two out of three Prx1-
CKO embryos analyzed at E16.5 (Fig. 5d). On the other hand,
bone mineralization was readily detectable by E18.5 in the
mutant, indicating only a modest delay in bone mineralization
caused by Glut1 deletion. Therefore, Glut1 is dispensable for
osteoblast differentiation but appears to play a role in supporting
the normal mineralizing activity of osteoblasts.
The use of Prx1-Cre does not distinguish the direct require-
ment for Glut1 in chondrocytes from potential indirect effects
from the other mesenchymal cell types in the limb. To overcome
this limitation, we deleted Glut1 with Col2-Cre that targets both
chondrocytes and osteoblasts but not the other limb mesench-
ymal cells. Similar to the Prx1-CKO mutants, the Col2-Cre;
Glut1f/f mice (Col2-CKO) exhibited severe shortening of the limb
skeletal elements coupled with no obvious columnar or
hypertrophic chondrocytes at E18.5 (Fig. 6a). Immunostaining
conﬁrmed that Glut1 was undetectable in the cartilage of Col2-
CKO embryos (Fig. 6b). Both the pan-hypertrophy marker ColX
and the terminal hypertrophy marker Mmp13 were absent in the
mutant cartilage (Fig. 6c, d). Moreover, chondrocyte proliferation,
as assayed by EdU labeling, was reduced by ~80% in the Col2-
CKO embryo (Fig. 6e). These results therefore support the notion
that Glut1 is directly required in chondrocytes for their proper
proliferation and hypertrophy.
Induction of Glut1 by Bmp2-mTORC1-Hif1a signaling. As
Bmp signaling is known to promote chondrocyte proliferation
and hypertrophy, we next tested the hypothesis that Bmp sig-
naling and Glut1 may be linked in the regulation. In keeping with












Fig. 5 Loss of Glut1 impedes mineralization of bone matrix at E16.5. a, b Immunoﬂuorescence staining of Sp7 (a) or Endomucin (b) on longitudinal sections











































Fig. 6 Deletion of Glut1 with Col2-Cre impairs chondrocyte proliferation and maturation. a H&E staining of longitudinal femoral sections from normal (Ctrl)
versus Col2-Cre; Glut1f/f (Col2-CKO) littermate embryos at E18.5. b–d Immunoﬂuorescence staining of Glut1 (b), ColX (c) or Mmp13 (d) on E18.5 femoral
sections. e EdU labeling of chondrocytes in the femur at E18.5. Signal is in red. *p < 0.05, n= 3 mice, error bar indicates SD, two-tailed Student’s t-test.
Scale bar: 200 µm
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-07316-5
6 NATURE COMMUNICATIONS |          (2018) 9:4831 | DOI: 10.1038/s41467-018-07316-5 | www.nature.com/naturecommunications
Cre resulted in shorter skeletal elements associated with dis-
organization of the columnar region and a diminished hyper-
trophic zone (Fig. 7a)19. Although the overall limb shortening
phenotype here was less severe, the defect in chondrocyte
maturation was qualitatively similar to that caused by Glut1
deletion. Importantly, immunoﬂuorescence staining showed that
Glut1 levels were markedly reduced in the columnar and
hypertrophic chondrocytes of the Col2-Cre; Bmpr1af/f embryos
(Fig. 7b). In addition, Hif1a, a known transcriptional activator for
Glut1, was also notably diminished in the columnar and hyper-
trophic cartilage in the absence of Bmpr1a (Fig. 7c). Thus, Bmp
signaling appears to function upstream of Glut1 in the developing
growth plate cartilage.
We then investigated the possibility that Bmp signaling might
directly modulate Glut1 expression. Treatment of primary
chondrocytes with recombinant BMP2 increased the protein
level of Glut1 by approximately twofold after 24 h, whereas
recombinant Igf1 or the Hh agonist purmorphamine, both also
known to regulate chondrocyte development, did not affect Glut1
levels (Fig. 8a). The BMP2 effect was time-dependent, as 6 h of
treatment did not increase Glut1 protein levels (Supplementary
Figure 4). Analyses of mRNA with RT-qPCR conﬁrmed that
Glut1 was the predominant isoform over Glut2, 3, and 4 in
chondrocytes, and that BMP2 speciﬁcally induced Glut1 mRNA
by over twofold after 24 h (Fig. 8b). Consistent with the induction
of Glut1, BMP2 stimulated glucose consumption by the
chondrocytes after 48 h (Fig. 8c). Thus, Bmp signaling induces
Glut1 expression and promotes glucose metabolism in primary
chondrocytes.
To elucidate the molecular mechanism responsible for Glut1
induction, we examined the role of Smad signaling downstream
of Bmp. Knockdown of Smad4 with two different shRNA notably
reduced the induction of Glut1 protein and mRNA by BMP2
(Fig. 8d, e). Although the result in itself suggests that the Smad
transcription factors might directly activate Glut1 gene transcrip-
tion in response to Bmp, a previous ChIP-seq study failed to
detect Smad4 binding in the promoter region (−5kb to +5b
around transcription start site) of the Glut1 gene in the
embryonic cartilage27. We therefore investigated the potential
role of mTORC1 signaling due to its known relevance in cellular
metabolism and its implication in Bmp signaling28. After 24 h of
treatment, BMP2 induced the phosphorylated fraction of S6 (P-
S6, a readout for mTORC1 activity) over the total S6 levels, but
the induction was diminished upon Smad4 knockdown (Fig. 8f).
As previous studies have shown that Smad4 reduces Pten mRNA
which encodes a negative regulator of mTORC1 activity, we
investigated Pten suppression as a potential mechanism for Bmp
to activate mTORC129,30. Indeed, BMP2 reduced Pten mRNA in
chondrocytes and the suppression was abolished upon Smad4
knockdown (Fig. 8g). In support of the functional importance of
mTORC1, inhibition of mTORC1 signaling with either rapamy-
cin or Torin1 abolished the induction of Glut1 by BMP2 while
also reducing the basal level of Glut1 (Fig. 9a). Similarly, the
induction of Glut1 mRNA was either completely abolished or
markedly suppressed by the mTOR inhibitors (Fig. 9b). There-
fore, Bmp signaling stimulates Glut1 expression likely down-
stream of Smad4 and mTORC1 activation.
We next explored the mechanism downstream of mTORC1
leading to Glut1 induction. As shown earlier, Hif1a was
diminished concurrently with Glut1 in the cartilage of Col2-Cre;
Bmpr1ac/c embryos (Fig. 7b, c). As a previous study has reported
that mTORC1 enhances the translation of Hif1a, we tested Hif1a
as a potential mediator of Bmp signaling in activating Glut1
expression31. BMP2 consistently induced Hif1a protein in
primary chondrocytes after 24 h, but the induction was abolished
by either rapamycin or Torin1 (Fig. 9c). Moreover, chemical
inhibition of Hif1a with either PX-478 or acriﬂavine dose-
dependently eliminated the induction of Glut1 by BMP2 (Fig. 9d).
Collectively, the results demonstrate that Bmp signaling upregu-
lates Glut1 through activation of mTORC1 and Hif1a in
chondrocytes.
Discussion
The present study provides genetic evidence, that the Glut1 glu-
cose transporter is required for speciﬁc aspects of endochondral
skeletal development. Deletion of Glut1 in the pre-chondrogenic












Fig. 7 Deletion of Bmpr1a with Col2-Cre disrupts chondrocyte maturation and reduces Glut1 expression. a Representative H&E staining of the femur from
normal (Ctrl) versus Col2-Cre; Bmpr1af/f littermate embryos at E18.5. Boxed areas shown at high magniﬁcation below. b, c Immunoﬂuorescence staining of
Glut1 (b) or Hif1a (c) in the femur at E18.5. Three littermate pairs were analyzed with similar results. Scale bar: 200 µm. Each image is representative of
three mice
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patterning or the initial expansion of the cartilage anlagen, but
essentially halts the subsequent longitudinal growth by impeding
chondrocyte proliferation and hypertrophy. Glut1 removal in the
cartilage anlage with Col2-Cre causes the same proliferation and
hypertrophy defects, thus arguing for a direct requirement for
Glut1 in chondrocytes. The study further identiﬁes Glut1 as a
downstream effector of Bmp signaling in cartilage development,
as genetic deletion of Bmpr1a diminishes Glut1 expression in the
growth plate whereas BMP2 induces Glut1 transcription via
mTORC1-Hif1a signaling in chondrocytes. The work therefore
highlights the coordination between growth factor signaling and
glucose metabolism during cartilage development.
Future studies are necessary to understand the biochemical
basis for glucose metabolism to control chondrocyte proliferation
and hypertrophy. The genetic roles uncovered here are consistent
with the modest yet widespread expression of Glut1 throughout
the growth plate, and a marked upregulation in the columnar and
early hypertrophic zones. Besides providing energy, glucose
supplies the carbon skeleton for biomass syntheses in the cell32.
In the proliferating chondrocytes, glucose metabolism likely
generates the intermediate metabolites necessary for de novo
synthesis of nucleotides and lipids in support of cell prolifera-
tion33. The upregulation of Glut1 in the columnar chondrocytes
likely reﬂects an increase in biosynthesis as those cells are not
only highly proliferative but also produce large quantities of
extracellular matrix proteins. Similarly, increased glucose meta-
bolism in the early hypertrophic chondrocytes corresponds to the
enhanced production of cellular dry mass3. The intensiﬁed bio-
synthesis in both columnar and early hypertrophic chondrocytes
is consistent with a strong mTORC1 activity in those cells34.
Thus, glucose metabolism as reﬂected by Glut1 expression closely
tracks with the biosynthetic activity of chondrocytes in the
developing growth plate.
It is somewhat unexpected that osteoblast differentiation
appears to be largely normal upon the deletion of Glut1. Previous
work has shown that glucose is a major nutrient for osteoblasts
and that both Wnt and PTH induce osteoblast differentiation and
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Fig. 8 BMP2 induces Glut1 expression via Smad4 and mTORC1. a Western blot analyses of primary chondrocytes after 24 h of treatment as indicated. b
RT-qPCR analyses in primary chondrocytes with or without BMP2 treatment for 24 h. *p < 0.05, n= 3, error bar indicates SD, two-tailed Student’s t-test. c
Glucose consumption by primary chondrocytes with or without BMP2 treatment for 48 h. Data normalized to genomic DNA. *p < 0.05, n= 3, error bar
indicates SD, two-tailed Student’s t-test. d, e Effects of Smad4 knockdown on Glut1 induction by BMP2 assayed by western blot (d) or RT-qPCR (e). shLuc
used as negative control. Two different Smad4 shRNA used. *p < 0.05, n= 3, error bar indicates SD, two-tailed Student’s t-test. f Western blot analyses of
Smad4 knockdown on BMP2-induced mTORC1 activation. g RT-qPCR analyses of Pten mRNA. *p < 0.05, n= 3, error bar indicates SD, two-tailed Student’s
t-test. Quantiﬁcation of all western blots denotes average fold change over vehicle control after normalization to β-actin (a, d) or total S6 (f) (±SD, n= 3)
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Glut1 is the main glucose transporter in osteoblast lineage cells
and has been shown to engage in a feedforward mechanism with
Runx2 to control the onset of osteoblast differentiation from the
progenitors26. Although we noted a lack of bone collar staining by
Alizarin Red in the limbs of Prx1-CKO embryos at E14.5, we
could not discern potential direct versus indirect effects on the
osteoblast lineage due to the concurrent defect in chondrocyte
hypertrophy. In any case, by E16.5 functional osteoblasts were
abundant in the bone collar, as indicated by Osx expression and
collagen I deposition. Thus, any requirement for Glut1 in
osteoblast differentiation appears to be transient. However, as von
Kossa staining detected a delay in bone matrix mineralization in
the E16.5 Prx1-CKO embryos, Glut1 may be important for sup-
porting the full range of osteoblast activity. The relative normalcy
of osteoblast differentiation in the absence of Glut1 may indicate
functional redundancy with the other glucose transporters.
However, we cannot rule out metabolic plasticity that may allow
the cells to switch to other nutrient substrates to support differ-
entiation when glucose metabolism is compromised.
Bmp signaling likely regulates cartilage development through
multiple mechanisms. Deletion of both Smad1 and Smad5 in
chondrocytes, similar to the double deletion of Bmpr1a and
Bmpr1b, results in the absence of most endochondral skeletal
elements, thus indicating that Smad1/5 are likely critical media-
tors of Bmp signaling in cartilage development40,41. Studies of the
cartilage remnants in the Smad1/5 double mutants have uncov-
ered profound defects in chondrocyte proliferation and hyper-
trophy41. Although Smad1/5 have been shown to activate the
transcription of Col10a1, a marker gene for chondrocyte
hypertrophy, the Smad target genes responsible for the hyper-
trophic program remain unknown42. Here we show that Smad4
at least partially mediates Bmp function in activating mTORC1
and Hif1a to enhance Glut1 transcription and glucose metabolism
in support of hypertrophy. Suppression of Pten appears to link
Bmp-Smad4 signaling to the activation of mTORC1, but how
Smad4 reduces Pten mRNA is unknown. Furthermore, addi-
tional further studies are warranted to determine whether loss of
Smad1/5 increases Pten and activates mTORC1 and glycolysis in
the cartilage in vivo. Finally, additional mechanisms beyond
Smad signaling may also contribute to mTORC1 activation in
response to Bmp.
The ﬁnding about the critical dependence of chondrocyte
hypertrophy on Glut1 may have practical implications. Although
articular cartilage normally maintains a stable state without
progressing through the maturation process as seen in the growth
plate, hypertrophy of articular chondrocytes commonly occurs in
osteoarthritis (OA) and is believed to contribute to the patho-
genesis43. Thus, suppressing Glut1 or other components of the
glycolytic pathway to prevent the abnormal hypertrophy may
help slowing down the progression of OA. In addition, current
efforts with articular cartilage replacement therapy are hampered
by unwanted progression of tissue-engineered cartilage towards
hypertrophy44. Therefore, inhibiting Glut1 activity might help
creating permanent hyaline cartilage in vitro for tissue therapy.
Methods
Mouse strains. Prx1-Cre45, Col2-Cre46, Glut1f/f 47, and Bmpr1af/f 48 mouse lines
have been previously reported. The Animal Studies Committee at Washington
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Fig. 9 Hif1α mediates Glut1 induction downstream of Bmp-mTORC1 signaling. a–c Western blot (a, c) or RT-qPCR (b) analyses in primary chondrocytes
after 24 h of BMP2 treatment with or without mTOR inhibitors. Rapa: rapamycin. d Western blot analyses in primary chondrocytes in response to BMP2
with or without the Hif1α inhibitors for 24 h. Quantiﬁcation of all western blots denotes average fold change over vehicle control after normalization to β-
actin (±SD, n= 3). *p < 0.05, n= 3, error bar indicates SD, two-tailed Student’s t-test
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Primary chondrocyte cultures. Primary chondrocytes were isolated from the rib
cages of 3-day-old C56BL6/J mice, and cultured in DMEM supplemented with 10%
FBS according to a published method49. Brieﬂy, the rib cages were dissected free of
soft tissues in cold PBS before being further cleaned up with 2 mg/ml of protease
(Sigma Aldrich, P6911I) in PBS and then 3 mg/ml of collagenase (Sigma Aldrich,
P6885) in PBS, each for 15 min at 37 °C with agitation. After three rinses with PBS,
the rib cages were digested with 0.3 mg/ml of collagenase in DMEM (Gibco,11965)
for overnight at 37 °C with 5% CO2. Primary chondrocytes were dissociated by
pipetting and passing through a 70 µm cell strainer (BD Falcon, 08-771-2), and
ﬁnally cultured in DMEM with 10% FBS. Subsequently, 2.5 × 105 cells were seeded
into each well of 24-well plates and grown to 80-90% conﬂuence before being
treated with 100 ng/ml BMP2 (R&D Systems, 355-BM-010), 100 ng/ml IGF1 (R&D
Systems, 791-MG-050) or 1 μM Purmorphamine (Millipore, 540223) for indicated
time. In certain experiments, BMP2 was used together with 100 nM Torin1
(Selleckchem, S2827) or 20 nM Rapamycin (Selleckchem, S1039) for 24 h. Glucose
consumption was measured with Glucose (HK) Assay Kit (Sigma Aldrich,
GAHK20). For shRNA knockdown experiments, Lentiviruses expressing shRNA
were produced by transfecting HEK293T cells with MISSION shRNA plasmids
targeting Smad4 (Sigma-Aldrich, TRCN0000025885, TRCN0000345739) or luci-
ferase as a negative control, together with the packaging plasmids pMD2.G and
psPAX2 by using the Fugen6 transfection reagent (Promega). The viral media was
added to the cells for 8 h before being replaced with fresh growth media for
additional 48 h. When BMP2 was used, the cells were then treated with BMP2 for
24 h before being harvested.
Analyses of mouse embryos. Both male and female embryos were used without
distinction in all analyses. Whole-mount embryonic skeleton was stained with
Alizarin Red/Alcian Blue according to a published method50. Brieﬂy, the embryos
were skinned, eviscerated, and ﬁxed in 95% ethanol for overnight and then changed
to acetone for 24 h. The embryos were then stained with Alcian Blue–Alizarin Red
staining solution containing 0.03% Alcian blue (Sigma Aldrich, A5268), 0.005%
Alizarin Red (Sigma Aldrich, A5533), 10% Glacial acetic acid and 80 % ethanol for
3 days. Subsequently embryos were transferred to 95% Ethanol for 4 h, and cleaned
up with 1% KOH (E16.5 and E18.5 embryos), or 0.5% KOH (E12.5 and E14.5), for
3 to 5 days. The embryos were cleared in 1 or 0.5% KOH plus 20% glycerol for 24
h, and subsequently in 1 or 0.5% KOH plus 50% glycerol for 24 h. The cleared
skeletons were stored in 1 or 0.5% KOH with 80% glycerol.
For analyses on sections, embryonic limbs were dissected out in PBS, ﬁxed in
10% neutral buffed formalin overnight at room temperature. For embryos older
than E16.5, the limbs were either decalciﬁed or non-decalciﬁed (see below) before
being processed for parafﬁn sectioning at 6 µm thickness. For von Kossa staining,
the limbs were non-decalciﬁed and the sections were stained with 2% silver nitrate
and counterstained with Nuclear Fast red. For H&E, Alcian blue/Picrosirius Red, or
Safarin O staining, the limbs were decalciﬁed for 3 days with 14% EDTA (pH 7.2)
prior to processing for parafﬁn sectioning.
Fluorescence staining. Pregnant female mice were injected intraperitoneally with
EdU (Thermo Fisher Scientiﬁc, C10339) at 10 µg/g body weight 2 h before harvest.
Embryonic limbs were dissected out, ﬁxed with 4% paraformaldehyde (EMS,
15710) overnight, decalciﬁed for 3 days with daily changes of 14% EDTA (pH 7.2),
and incubated in 30% sucrose overnight for cryoprotection prior to embedding in
optimal cutting temperature (OCT) (Tissue-Tek, 4583). Sections of 10 μm in
thickness were obtained with a Leica cryostat equipped with Cryojane (Leica). EdU
was detected by a Click reaction performed according to the manufacturer’s
instructions. TUNEL assay was performed with the In-Situ Cell Death Detection
Kit Fluorescein (Roche, 11684795910). For immunostaining, the frozen sections
were stained with speciﬁc antibodies against Glut1 (Santa Cruz, SC-7903), Endo-
mucin (Santa Cruz, SC-65495), Osterix (Abcam, ab22552), Mmp13 (Abcam,
ab39012), or Collagen type X (DSHB Hybridoma Product, X-AC9). The secondary
antibodies were as follows: Alexa Fluor Alexa Fluor 488 goat anti-rabbit IgG (Life
Science, A-11034), Alexa Fluor 594 goat anti-rabbit IgG (Life Science, R37117).
Stained section were mounted with VECTASHIELD mounting medium containing
DAPI (Vector Laboratories, H-1200).
Western blots. Total protein extracts were prepared from primary chondrocytes
using RIPA buffer (Cell signaling, 9806) containing proteinase inhibitors and
phosphatase inhibitors (Thermo Fisher Scientiﬁc, 78442). 10 µg of total protein was
resolved by electrophoresis on Mini-PROTEAN® TGX™ Precast Gel (Bio-Rad),
transferred onto a 0.45-μm pore PVDF Immobilon-P membrane (Millipore), and
detected with a speciﬁc antibody against S6 (Cell Signaling, 2215), P-S6(S240/244)
(Cell Signaling, 9452), β-Actin (Cell Signaling, 4970), Glut1 (Santa Cruz, SC-7903),
or Hif1α (Novus, NB100-479). Membranes were blocked for 1 h at room tem-
perature in 5% BSA (Roche) in TBS containing 0.1% Tween-20 (TBS-T) before
overnight incubation with the primary antibody at 4 °C. The membranes were then
washed with TBS-T, and further incubated at room temperature for 1.5 h with a
HRP-conjugated anti-rabbit (GE Healthcare, NA934V) or anti-mouse (Cell Sig-
naling, 7076S) secondary antibody. All blots were developed by using the Clarity
Substrate Kit (Bio-Rad). Gel images were captured with Chemidoc (Bio-Rad). Each
experiment was repeated with a minimum of three independently prepared protein
samples. The uncropped blot images are provided in Supplementary Figure 5.
RT-qPCR. Total RNA was isolated from primary chondrocyte cultures or
embryonic epiphyseal cartilage with RNeasy mini kit (Qiagen, 74104). The epi-
physeal cartilage was dissected from both forelimbs and the hindlimbs, treated with
0.25% trypsin EDTA for 15 min at 37 °C to remove the surrounding connective
tissues, and then rinsed with Hank’s Balanced Salt Solution (HBSS). Reverse
transcription was performed using 500 ng of total RNA with iScriptTM reverse
transcription super mix (Bio-Rad, 1708891). qPCR reactions were set up in a 96-
well format on an ABI StepOne Plus using SsoAdvancedTM universal CYBR Green
Supermix (Bio-Rad, 1725274). β-actin was used for normalization in most cases
unless otherwise indicated, and relative expression was calculated by the 2−(ΔΔCT)
method.
Data availability
The authors declare that all data supporting the ﬁndings of this study are available
within the Article and its Supplementary Information ﬁles or from the corre-
sponding author upon reasonable request.
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